000 | 01365 a2200397 4500 | ||
---|---|---|---|
005 | 20250512203236.0 | ||
264 | 0 | _c19840727 | |
008 | 198407s 0 0 eng d | ||
022 | _a0031-4005 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHaslam, R H | |
245 | 0 | 0 |
_aEffects of megavitamin therapy on children with attention deficit disorders. _h[electronic resource] |
260 |
_bPediatrics _cJul 1984 |
||
300 |
_a103-11 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnalysis of Variance |
650 | 0 | 4 |
_aAscorbic Acid _xadministration & dosage |
650 | 0 | 4 |
_aAttention Deficit Disorder with Hyperactivity _xdrug therapy |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aNiacinamide _xadministration & dosage |
650 | 0 | 4 |
_aOrthomolecular Therapy _xadverse effects |
650 | 0 | 4 |
_aPantothenic Acid _xadministration & dosage |
650 | 0 | 4 |
_aPyridoxine _xadministration & dosage |
650 | 0 | 4 | _aRandom Allocation |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aTransaminases _xblood |
700 | 1 | _aDalby, J T | |
700 | 1 | _aRademaker, A W | |
773 | 0 |
_tPediatrics _gvol. 74 _gno. 1 _gp. 103-11 |
|
999 |
_c6234484 _d6234484 |